Literature DB >> 3031498

Studies on the pathogenesis of vincristine-induced neuropathy.

Z Sahenk, S T Brady, J R Mendell.   

Abstract

The pathogenesis of the peripheral neuropathy induced by vincristine is poorly understood, but interference of vinca alkaloids with microtubule assembly suggests that microtubule changes could be important. This possibility was studied by directly exposing the rat sciatic nerve to graded concentrations of vincristine sulfate. Microtubule length histograms prepared from randomly selected axons showed a unimodal distribution in vincristine and control axons. In vincristine-exposed axons, however, there was a shift to shorter length microtubules, and the mean measured length of microtubules (0.42 +/- 0.37 micron) was significantly (P less than 0.001) shorter than controls (0.67 +/- 0.55 micron). On cross-sections, the vincristine-exposed axons showed a decrease in the number of microtubules per square micrometer of axonal area compared to controls. These findings fit best with a loss of portion(s) of each microtubule and support the possibility that microtubules changes were associated with malorientation of microtubules and neurofilaments, accompanied by free vesicle accumulation and fragmentation of the smooth endoplasmic reticulum. These structural alterations would account for the previously observed abnormalities in axoplasmic transport and would also provide insight into the commonly observed peripheral neuropathy induced by vincristine treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031498     DOI: 10.1002/mus.880100115

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

1.  Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.

Authors:  Nichole E LaPointe; Gerardo Morfini; Scott T Brady; Stuart C Feinstein; Leslie Wilson; Mary Ann Jordan
Journal:  Neurotoxicology       Date:  2013-05-24       Impact factor: 4.294

Review 2.  HIV-associated neuropathic pain: epidemiology, pathophysiology and management.

Authors:  Susama Verma; Lydia Estanislao; David Simpson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Exogenously administered gangliosides fail to increase in vivo metastatic frequency or in vitro growth of murine neoplastic cells.

Authors:  L Facci; S D Skaper; D Presti; G Kirschner; A Leon; L Chieco-Bianchi
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

Review 4.  Toxic Peripheral Neuropathies: Agents and Mechanisms.

Authors:  William M Valentine
Journal:  Toxicol Pathol       Date:  2019-06-10       Impact factor: 1.902

5.  Long-term effects of vincristine on the peripheral nervous system.

Authors:  T J Postma; B A Benard; P C Huijgens; G J Ossenkoppele; J J Heimans
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

Review 6.  Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

Authors:  Wolfgang Grisold; Guido Cavaletti; Anthony J Windebank
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

7.  Retardation of rat sciatic nerve regeneration after local application of minute doses of vincristine.

Authors:  G S Ruigt; M H den Brok
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine.

Authors:  Serkan Feyyaz Yalin; Sinan Trabulus; Ayse Serap Yalin; Gulsah Yenidunya Yalin; Seniz Ongoren; Mehmet Riza Altiparmak
Journal:  Int J Clin Pharm       Date:  2013-01-22

9.  Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma.

Authors:  S Koeppen; C C P Verstappen; R Körte; M E Scheulen; D Strumberg; T J Postma; J J Heimans; P C Huijgens; B Kiburg; K Renzing-Köhler; H C Diener
Journal:  J Cancer Res Clin Oncol       Date:  2004-01-16       Impact factor: 4.553

10.  Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nerves.

Authors:  F Di Gregorio; G Favaro; C Panozzo; M G Fiori
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.